Skip to main content
logo
Aceso Life Science Group Limited (HKG:0474)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1500
-0.0020 (-1.32%)
Sep 11, 2026, 3:58 PM HKT

Aceso Life Science Group Financials Overview

Millions HKD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
-59-59-13911207170
Revenue Growth
----94.69%21.77%-
Operating Income
-141-141-203-224-90-136
Net Income
338338-757-462-264-370
Earnings Per Share
0.050.05-0.11-0.06-0.04-0.06
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
326326212469602717
Total Debt
1,2081,2082,3112,7382,9223,010
Net Cash (Debt)
-882-882-2,099-2,269-2,320-2,293
Net Cash Growth
------
Net Cash Per Share
-0.12-0.12-0.29-0.31-0.32-0.31

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
202017-37214316
Capital Expenditures
---2-11-24-57
Free Cash Flow
202015-48190259
Free Cash Flow Growth
-82.76%33.33%---26.64%57.93%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Margin
----2036.36%-43.48%-80.00%
Pretax Margin
713.56%713.56%474.10%-7481.82%-102.90%-326.47%
Profit Margin
----4200.00%-127.54%-217.65%
FCF Margin
----436.36%91.79%152.35%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
3.933.12----
P/FCF Ratio
66.4452.7124.61-6.921.82
PS Ratio
-22.52-17.87-2.65106.706.352.78